Sofosbuvir/velpatasvir for chronic hepatitis C infection in patients with transfusion-dependent thalassemia

被引：9

作者：

Sharara, Ala I. ^{[1
]}

Rustom, Luma Basma O. ^{[1
]}

Marrache, Majd ^{[1
]}

Rimmani, Hussein H. ^{[1
]}

Daher, Halim Bou ^{[1
]}

Koussa, Suzanne ^{[2
]}

Taher, Ali ^{[3
]}

机构：

[1] Amer Univ Beirut, Med Ctr, Dept Internal Med, Div Gastroenterol, Beirut, Lebanon

[2] Chron Care Ctr, Hazmieh, Lebanon

[3] Amer Univ Beirut, Med Ctr, Dept Internal Med, Div Hematol Oncol, Beirut, Lebanon

来源：

AMERICAN JOURNAL OF HEMATOLOGY | 2019年 / 94卷 / 02期

关键词：

VIRUS-INFECTION; MAJOR PATIENTS; SOFOSBUVIR; DACLATASVIR; EFFICACY;

D O I：

10.1002/ajh.25339

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E43 / E45

页数：3

共 8 条

[1] Liver disease in chelated transfusion-dependent thalassemics:: the role of iron overload and chronic hepatitis C
Di Marco, Vito
Capra, Marcello
Gagliardotto, Francesco
Borsellino, Zelia
Cabibi, Daniela
Barbaria, Francesco
Ferraro, Donatella
Cuccia, Liana
Ruffo, Giovanni Battista
Bronte, Fabrizio
Di Stefano, Rosa
Almasio, Piero L.
Craxi, Antonio
[J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 (08): : 1243 - 1246
[2] Hézode C, 2017, HEPATOLOGY, V66, P736, DOI [10.1002/hep.29139, 10.1002/hep.291]
[3] Efficacy and tolerability of peginterferon alpha-2a with or without ribavirin in thalassaemia major patients with chronic hepatitis C virus infection
Inati, A
Taher, A
Ghorra, S
Koussa, S
Taha, M
Aoun, E
Sharara, AI
[J]. BRITISH JOURNAL OF HAEMATOLOGY, 2005, 130 (04) : 644 - 646
[4] Randomised clinical trial: sofosbuvir and ledipasvir in patients with transfusion-dependent thalassaemia and HCV genotype 1 or 4 infection
Mangia, A.
Sarli, R.
Gamberini, R.
Piga, A.
Cenderello, G.
Piazzolla, V.
Santoro, R.
Caruso, V.
Quarta, A.
Ganga, R.
Copetti, M.
Forni, G.
[J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 46 (04) : 424 - 431
[5] Safety and Efficacy of Sofosbuvir and Daclatasvir for Hepatitis C Virus Infection in Patients with beta-Thalassemia Major
Mehta, Rajiv
Kabrawala, Mayank
Nandwani, Subhash
Desai, Pankaj
Bhayani, Vishwa
Patel, Sanjay
Parekh, Viral
[J]. JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2018, 8 (01) : 3 - 6
[6] Treatment of hepatitis C virus infection with direct-acting antiviral drugs is safe and effective in patients with hemoglobinopathies
Origa, Raffaella
Ponti, Maria Laura
Filosa, Aldo
Lanza, Alfonso Galeota
Piga, Antonio
Saracco, Giorgio Maria
Pinto, Valeria
Picciotto, Antonino
Rigano, Paolo
Madonia, Salvatore
Rosso, Rosamaria
D'Ascola, Domenico
Cappellini, Maria Domenica
D'Ambrosio, Roberta
Tartaglione, Immacolata
De Franceschi, Lucia
Gianesin, Barbara
Di Marco, Vito
Forni, Gian Luca
[J]. AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (12) : 1349 - 1355
[7] Treatment of chronic hepatitis C with direct-acting antivirals in patients with β-thalassaemia major and advanced liver disease
Sinakos, Emmanouil
Kountouras, Dimitrios
Koskinas, John
Zachou, Kalliopi
Karatapanis, Stylianos
Triantos, Christos
Vassiliadis, Themistoklis
Goulis, Ioannis
Kourakli, Alexandra
Vlachaki, Efthymia
Toli, Barbara
Tampaki, Maria
Arvaniti, Pinelopi
Tsiaoussis, Georgios
Bellou, Aristea
Kattamis, Antonis
Maragkos, Konstantinos
Petropoulou, Foteini
Dalekos, George N.
Akriviadis, Evangelos
Papatheodoridis, George V.
[J]. BRITISH JOURNAL OF HAEMATOLOGY, 2017, 178 (01) : 130 - 136
[8] Zamani F, 2018, INDIAN J MED MICROBI, V36, P224, DOI [10.4103/ijmm.IJMM_18_90, 10.4103/ijmm.ijmm_18_90]

← 1 →